FRONTIER MEDICINES ANNOUNCES FDA ALLOWANCE TO PROCEED UNDER AN IND FOR FMC-242, A NOVEL COVALENT ALLOSTERIC PI3KΑ-RAS BREAKER, IN PATIENTS WITH SELECT ADVANCED SOLID TUMORS

Reuters · 3d ago

Please log in to view news